Tuesday, April 25, 2006
Action Alerts Plus: Update on FWLT and CEPH
Cramer is out defending FWLT-- as it drops 3% during today's session. He also hypes Cephalon's attention deficit disorder drug, Sparlon. He feels its only a matter of time until it gets FDA approval.
With that being said, Cramer recommends selling some CEPH here, if you were lucky enough to buy in around $60 a few weeks ago.
With that being said, Cramer recommends selling some CEPH here, if you were lucky enough to buy in around $60 a few weeks ago.
